Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lavecchia

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Antiviral Chemistry & Chemotherapy|May 20, 2000
Structure-activity relationship studies on potential non-nucleoside DABO-like inhibitors of HIV-1 reverse transcriptaseR Costi, R Di Santo, M Artico, et al.
Journal of Medicinal Chemistry|June 8, 2000
Synthesis, molecular modeling, and opioid receptor affinity of 9, 10-diazatricyclo[4.2.1.1(2,5)]decanes and 2,7-diazatricyclo[4.4.0. 0(3,8)]decanes structurally related to 3,8-diazabicyclo[3.2. 1]octanesP Vianello, A Albinati, G A Pinna, et al.
Bioorganic & Medicinal Chemistry|October 12, 2000
Computer-assisted design, synthesis and biological evaluation of novel pyrrolyl heteroaryl sulfones targeted at HIV-1 reverse transcriptase as non-nucleoside inhibitorsR Silvestri, M Artico, G De Martino, et al.
Journal of Medicinal Chemistry|December 1, 2001
[1,2,4]Triazino[4,3-a]benzimidazole acetic acid derivatives: a new class of selective aldose reductase inhibitorsF Da Settimo, G Primofiore, A Da Settimo, et al.
Journal of Medicinal Chemistry|July 21, 2001
3-Aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: a new class of selective A1 adenosine receptor antagonistsF Da Settimo, G Primofiore, S Taliani, et al.
Journal of Medicinal Chemistry|June 29, 2001
Novel N-(arylalkyl)indol-3-ylglyoxylylamides targeted as ligands of the benzodiazepine receptor: synthesis, biological evaluation, and molecular modeling analysis of the structure-activity relationshipsG Primofiore, F D Settimo, S Taliani, et al.
Journal of Neuroscience Research|January 13, 2015
Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stressGaurav Bedse, Adele Romano, Bianca Tempesta, et al.
Journal of Medicinal Chemistry|November 23, 2012
New 2-(aryloxy)-3-phenylpropanoic acids as peroxisome proliferator-activated receptor α/γ dual agonists able to upregulate mitochondrial carnitine shuttle system gene expressionA Laghezza, G Pochetti, A Lavecchia, et al.
Journal of Medicinal Chemistry|July 27, 2001
Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptaseA Mai, G Sbardella, M Artico, et al.
Journal of Medicinal Chemistry|November 16, 2011
Synthesis, characterization and biological evaluation of ureidofibrate-like derivatives endowed with peroxisome proliferator-activated receptor activityL Porcelli, F Gilardi, A Laghezza, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Antiviral Chemistry & Chemotherapy|May 20, 2000
Structure-activity relationship studies on potential non-nucleoside DABO-like inhibitors of HIV-1 reverse transcriptaseR Costi, R Di Santo, M Artico, et al.
Journal of Medicinal Chemistry|June 8, 2000
Synthesis, molecular modeling, and opioid receptor affinity of 9, 10-diazatricyclo[4.2.1.1(2,5)]decanes and 2,7-diazatricyclo[4.4.0. 0(3,8)]decanes structurally related to 3,8-diazabicyclo[3.2. 1]octanesP Vianello, A Albinati, G A Pinna, et al.
Bioorganic & Medicinal Chemistry|October 12, 2000
Computer-assisted design, synthesis and biological evaluation of novel pyrrolyl heteroaryl sulfones targeted at HIV-1 reverse transcriptase as non-nucleoside inhibitorsR Silvestri, M Artico, G De Martino, et al.
Journal of Medicinal Chemistry|December 1, 2001
[1,2,4]Triazino[4,3-a]benzimidazole acetic acid derivatives: a new class of selective aldose reductase inhibitorsF Da Settimo, G Primofiore, A Da Settimo, et al.
Journal of Medicinal Chemistry|July 21, 2001
3-Aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: a new class of selective A1 adenosine receptor antagonistsF Da Settimo, G Primofiore, S Taliani, et al.
Journal of Medicinal Chemistry|June 29, 2001
Novel N-(arylalkyl)indol-3-ylglyoxylylamides targeted as ligands of the benzodiazepine receptor: synthesis, biological evaluation, and molecular modeling analysis of the structure-activity relationshipsG Primofiore, F D Settimo, S Taliani, et al.
Journal of Neuroscience Research|January 13, 2015
Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stressGaurav Bedse, Adele Romano, Bianca Tempesta, et al.
Journal of Medicinal Chemistry|November 23, 2012
New 2-(aryloxy)-3-phenylpropanoic acids as peroxisome proliferator-activated receptor α/γ dual agonists able to upregulate mitochondrial carnitine shuttle system gene expressionA Laghezza, G Pochetti, A Lavecchia, et al.
Journal of Medicinal Chemistry|July 27, 2001
Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptaseA Mai, G Sbardella, M Artico, et al.
Journal of Medicinal Chemistry|November 16, 2011
Synthesis, characterization and biological evaluation of ureidofibrate-like derivatives endowed with peroxisome proliferator-activated receptor activityL Porcelli, F Gilardi, A Laghezza, et al.
Pageof 2